Companies / Adaptive Biotechnologies Corp / Activity
Activity — Adaptive Biotechnologies Corp
147 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Robins Chad M CEO | Sell | Common Stock | $4.57M | -289K -12.70% | 1,987,330 1.25% of shares | medium |
| Mar 11, 2026 | Robins Harlan S Executive | Sell | Common Stock | $4.34M | -330K -17.80% | 1,522,058 0.95% of shares | medium |
| Mar 11, 2026 | Robins Chad M CEO | Sell | Common Stock | $4.34M | -330K -12.53% | 2,301,113 1.44% of shares | medium |
| Feb 27, 2026 | Robins Chad M CEO | Sell | Common Stock | $2.92M | -183K -7.44% | 2,276,354 1.43% of shares | medium |
| Feb 2, 2026 | Robins Chad M CEO | Sell | Common Stock | $2.30M | -125K -4.84% | 2,459,245 1.54% of shares | medium |
| Jan 5, 2026 | Robins Chad M CEO | Sell | Common Stock | $1.95M | -125K -4.61% | 2,584,243 1.62% of shares | medium |
| Mar 11, 2026 | Robins Harlan S Executive | Sell | Common Stock | $1.85M | -141K -7.06% | 1,851,658 1.16% of shares | medium |
| Mar 11, 2026 | Robins Chad M CEO | Sell | Common Stock | $1.85M | -141K -5.07% | 2,630,713 1.65% of shares | medium |
| Mar 11, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $1.61M | -123K -19.04% | 520,948 0.33% of shares | medium |
| Jan 12, 2026 | Lo Francis Executive | Sell | Common Stock | $1.41M | -80K -20.12% | 315,978 0.20% of shares | medium |
| Jun 25, 2026 | Griffin Michelle Renee Director | Sell | Common Stock | $1.05M | -52K -76.92% | 15,625 <0.01% of shares | medium |
| Mar 11, 2026 | Benzeno Sharon Executive | Sell | Common Stock | $831.1K | -63K -18.79% | 272,751 0.17% of shares | medium |
| Mar 3, 2026 | Robins Chad M CEO | Sell | Common Stock | $785.4K | -51K -2.55% | 1,936,627 1.21% of shares | medium |
| Mar 3, 2026 | Griffin Michelle Renee Director | Sell | Common Stock | $735.1K | -48K -75.73% | 15,394 <0.01% of shares | medium |
| Feb 2, 2026 | Robins Harlan S Executive | Sell | Common Stock | $644.8K | -35K -2.84% | 1,187,644 0.74% of shares | medium |
| Mar 5, 2026 | Lo Francis Executive | Sell | Common Stock | $574.5K | -38K -10.57% | 321,967 0.20% of shares | medium |
| Mar 11, 2026 | Bobulsky Susan Executive | Sell | Common Stock | $544.4K | -41K -8.81% | 427,775 0.27% of shares | medium |
| Mar 4, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $513.6K | -31K -5.07% | 579,573 0.36% of shares | medium |
| Mar 5, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $495.1K | -31K -5.10% | 575,235 0.36% of shares | medium |
| Mar 6, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $468.4K | -31K -4.53% | 652,147 0.41% of shares | medium |
| Mar 9, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $457.6K | -31K -4.56% | 647,809 0.41% of shares | medium |
| Mar 11, 2026 | Lo Francis Executive | Sell | Common Stock | $430.7K | -31K -9.50% | 291,374 0.18% of shares | medium |
| Jun 25, 2026 | Griffin Michelle Renee Director | Exercise | Common Stock | $406.3K | +52K +333.34% | 67,709 0.04% of shares | low |
| Mar 3, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $378.3K | -24K -3.97% | 590,429 0.37% of shares | medium |
| Jan 12, 2026 | Lo Francis Executive | Exercise | Common Stock | $285.9K | +37K +11.60% | 352,628 0.22% of shares | low |
| Mar 10, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $285.7K | -19K -2.94% | 643,471 0.40% of shares | medium |
| Mar 25, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $272.0K | -19K -3.87% | 473,230 0.30% of shares | medium |
| Mar 26, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $269.1K | -19K -3.91% | 468,892 0.29% of shares | medium |
| Mar 11, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $268.4K | -19K -3.56% | 516,610 0.32% of shares | medium |
| Mar 23, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $263.6K | -19K -3.80% | 481,906 0.30% of shares | medium |
| Mar 24, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $261.1K | -19K -3.84% | 477,568 0.30% of shares | medium |
| Mar 31, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $256.4K | -19K -4.01% | 455,878 0.29% of shares | medium |
| Mar 16, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $255.6K | -19K -3.65% | 503,596 0.32% of shares | medium |
| Mar 17, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $255.4K | -19K -3.68% | 499,258 0.31% of shares | medium |
| Mar 20, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $254.8K | -19K -3.77% | 486,244 0.30% of shares | medium |
| Mar 19, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $251.2K | -19K -3.74% | 490,582 0.31% of shares | medium |
| Mar 18, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $251.2K | -19K -3.71% | 494,920 0.31% of shares | medium |
| Mar 13, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $247.0K | -19K -3.62% | 507,934 0.32% of shares | medium |
| Mar 11, 2026 | Piskel Kyle Executive | Sell | Common Stock | $245.9K | -19K -6.70% | 259,840 0.16% of shares | medium |
| Mar 30, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $240.7K | -19K -3.98% | 460,216 0.29% of shares | medium |
| Mar 3, 2026 | Robins Harlan S Executive | Sell | Common Stock | $235.1K | -14K -1.22% | 1,155,291 0.72% of shares | medium |
| Mar 27, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $220.0K | -16K -3.39% | 464,554 0.29% of shares | medium |
| Mar 11, 2026 | Griffin Michelle Renee Director | Sell | Common Stock | $214.1K | -15K -49.63% | 15,625 <0.01% of shares | medium |
| Mar 3, 2026 | Griffin Michelle Renee Director | Exercise | Common Stock | $191.7K | +48K +312.10% | 63,438 0.04% of shares | low |
| Jan 12, 2026 | Lo Francis Executive | Exercise | Common Stock | $177.7K | +21K +5.83% | 381,353 0.24% of shares | low |
| Mar 12, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $172.5K | -14K -2.57% | 517,672 0.32% of shares | medium |
| Jan 6, 2026 | Robins Harlan S Executive | Sell | Common Stock | $164.4K | -10K -0.81% | 1,222,312 0.77% of shares | medium |
| Mar 2, 2026 | Robins Harlan S Executive | Sell | Common Stock | $157.2K | -10K -0.85% | 1,169,524 0.73% of shares | medium |
| Feb 3, 2026 | Robins Harlan S Executive | Sell | Common Stock | $154.3K | -8K -0.68% | 1,179,524 0.74% of shares | medium |
| Mar 9, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $144.2K | +12K +1.78% | 678,750 0.43% of shares | low |